ERBITUX EXPANDS THE POSSIBILITIES OF CANCER THERAPY Trademark
ERBITUX EXPANDS THE POSSIBILITIES OF CANCER THERAPY is a USPTO trademark filed by ImClone Systems Incorporated. Status: Abandoned.
Trademark Facts
| Mark | ERBITUX EXPANDS THE POSSIBILITIES OF CANCER THERAPY |
|---|---|
| Serial Number | 76547822 |
| Status | Abandoned |
| Filing Date | 2003-09-24 |
| Mark Type | Word |
| Nice Classes | 044 (Medical Services) |
| Owner | ImClone Systems Incorporated |
| Attorney of Record | Robert M. Kunstadt |
| Prosecution Events | 13 |
| Latest Event | ABN6 on 2005-10-17 |
Goods & Services
MEDICAL INFORMATION SERVICES RENDERED TO THE PUBLIC BY MEANS OF A GLOBAL COMPUTER INFORMATION NETWORK, PERTAINING TO CANCER, CANCER RESEARCH, TREATMENT OF CANCER, PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER, VACCINES AND DIAGNOSTIC PREPARATIONS